Literature DB >> 16936820

Epigenetic tête-à-tête: the bilateral relationship between chromatin modifications and DNA methylation.

Ana C D'Alessio1, Moshe Szyf.   

Abstract

The epigenome, which comprises chromatin, associated proteins, and the pattern of covalent modification of DNA by methylation, sets up and maintains gene expression programs. It was originally believed that DNA methylation was the dominant reaction in determining the chromatin structure. However, emerging data suggest that chromatin can affect DNA methylation in both directions, triggering either de novo DNA methylation or demethylation. These events are particularly important for the understanding of cellular transformation, which requires a coordinated change in gene expression profiles. While genetic alterations can explain some of the changes, the important role of epigenetic reprogramming is becoming more and more evident. Cancer cells exhibit a paradoxical coexistence of global loss of DNA methylation with regional hypermethylation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936820     DOI: 10.1139/o06-090

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  38 in total

Review 1.  DNA methylation topology: potential of a chromatin landmark for epigenetic drug toxicology.

Authors:  Jian Tajbakhsh
Journal:  Epigenomics       Date:  2011-12       Impact factor: 4.778

2.  Early demethylation of non-CpG, CpC-rich, elements in the myogenin 5'-flanking region: a priming effect on the spreading of active demethylation.

Authors:  Andrea Fuso; Giampiero Ferraguti; Francesco Grandoni; Raffaella Ruggeri; Sigfrido Scarpa; Roberto Strom; Marco Lucarelli
Journal:  Cell Cycle       Date:  2010-10-29       Impact factor: 4.534

Review 3.  Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention.

Authors:  B Stefanska; H Karlic; F Varga; K Fabianowska-Majewska; Ag Haslberger
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 4.  Epigenetics in acute myeloid leukemia.

Authors:  Christoph Plass; Christopher Oakes; William Blum; Guido Marcucci
Journal:  Semin Oncol       Date:  2008-08       Impact factor: 4.929

5.  The implications of DNA methylation for toxicology: toward toxicomethylomics, the toxicology of DNA methylation.

Authors:  Moshe Szyf
Journal:  Toxicol Sci       Date:  2011-02-04       Impact factor: 4.849

Review 6.  Epigenetic mechanisms in cognition.

Authors:  Jeremy J Day; J David Sweatt
Journal:  Neuron       Date:  2011-06-09       Impact factor: 17.173

Review 7.  Epigenome manipulation as a pathway to new natural product scaffolds and their congeners.

Authors:  Robert H Cichewicz
Journal:  Nat Prod Rep       Date:  2009-10-27       Impact factor: 13.423

Review 8.  Histone demethylases and cancer.

Authors:  Sotirios C Kampranis; Philip N Tsichlis
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

Review 9.  Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?

Authors:  Christopher A Shaw; Günter U Höglinger
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

10.  Epigenetics, behaviour, and health.

Authors:  Moshe Szyf; Michael J Meaney
Journal:  Allergy Asthma Clin Immunol       Date:  2008-03-15       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.